Nirmidas Biotech develops pGOLD, a plasmonic gold technology that enhances near-infrared fluorescence signal for bio-analytical and diagnostic researchers. The technology was optimized over nearly a decade of research at Stanford University. The company provides solutions aimed at bio-analytical and diagnostic research workflows. It is led by scientific co-founder Dr. Hongjie Dai and CEO/co-founder Dr. Meijie Tang. Nirmidas is a resident at Janssen Labs @QB3 and StartX Med. The company intends to use newly raised funds to commercialize the pGOLD platform. The article reports a $2M seed financing.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Aug 2014